---
layout: post
title: "亿帆医药：盐酸去氧肾上腺素注射液注册上市许可申请获受理"
date: 2022-02-17 18:47:23 +0800
categories: cailianshe
tags: 财联社新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.002019" data-code="002019|0|2" data-code2="002019|0|6|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.002019&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 002019_0" data-code="K 002019|0|2" data-code2="K 002019|0|6|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>亿帆医药公告，全资子公司合肥亿帆生物制药16日收到国家药监局签发的盐酸去氧肾上腺素注射液境内注册上市许可申请《受理通知书》。盐酸去氧肾上腺素注射液适用于治疗麻醉状态下由血管扩张引起的低血压。<br /></p><p class="em_media">（文章来源：财联社）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202202172280256423>

[返回财联社新闻](//finews.withounder.com/category/cailianshe.html)｜[返回首页](//finews.withounder.com/)